Anebulo Pharmaceuticals Inc.

07/05/2022 | Press release | Distributed by Public on 07/05/2022 04:06

Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication